Real-time enrollment status for this b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:34 AM UTC
| NCT Number | NCT06088654 |
| Recruiting Status | Recruiting |
| Condition | B-Cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 184 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Innate Pharma |
| Last Updated on CT.gov | April 2, 2025 (Apr 2, 2025) |
As of March 2, 2026: Clinical trial NCT06088654 is currently recruiting participants. This clinical trial study for b-cell lymphoma is actively seeking new participants at 5 locations across the United States. The study is sponsored by Innate Pharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06088654 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06088654 was last updated Apr 2, 2025 (April 2, 2025). HelloStudys verifies this status automatically.